# Dermata Therapeutics, Inc.: filings

DRMA · Nasdaq · CIK 1853816 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/drma.md) · [Financials](/companies/drma/financials.md) · [Filings](/companies/drma/filings.md) · [Insiders](/companies/drma/insiders.md)

## Reports and events: 132 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 89, 8-K 77, CORRESP 21, 10-Q 16, UPLOAD 14, 3 13, EFFECT 13, 424B3 12, S-3 9, SCHEDULE 13G/A 8, DEF 14A 7, S-1/A 7, SCHEDULE 13D/A 7, DEFA14A 6, PRE 14A 6, 10-K 5, 424B5 5, S-1 5, S-8 5, 424B4 4, ARS 4, D 4, SC 13D/A 4, SCHEDULE 13G 4, SEC STAFF LETTER 3, DRS 2, FWP 2, SC 13D 2, SC 13G 2, 10-K/A 1, 25-NSE 1, 8-A12B 1, CERT 1, D/A 1, DRS/A 1, DRSLTR 1, POS EX 1, RW 1, S-1MEF 1, S-3/A 1, SC 13G/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-17 | 08:30 ET | [8-K](/filings/0001493152-26-038647.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038647 |
| 2026-08-11 | 16:07 ET | [10-Q](/filings/0001493152-26-037127.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037127 |
| 2026-08-11 | 16:06 ET | [8-K](/filings/0001493152-26-037124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037124 |
| 2026-08-05 | 08:30 ET | [8-K](/filings/0001493152-26-036109.md) | 8.01 Other events | 0001493152-26-036109 |
| 2026-06-01 | 16:34 ET | [SCHEDULE 13D](/filings/0001493152-26-026642.md) | Ownership report, active investor | 0001493152-26-026642 |
| 2026-05-27 | 16:57 ET | [8-K](/filings/0001493152-26-025441.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-025441 |
| 2026-05-13 | 16:08 ET | [10-Q](/filings/0001493152-26-022719.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022719 |
| 2026-05-13 | 16:05 ET | [8-K](/filings/0001493152-26-022710.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022710 |
| 2026-04-17 | 17:01 ET | [DEF 14A](/filings/0001493152-26-017909.md) | Proxy statement, period 2026-04-17 | 0001493152-26-017909 |
| 2026-03-26 | 17:17 ET | [10-K](/filings/0001493152-26-012992.md) | Annual report, period 2025-12-31 | 0001493152-26-012992 |
| 2026-03-26 | 17:16 ET | [8-K](/filings/0001493152-26-012991.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012991 |
| 2026-02-25 | 16:05 ET | [8-K](/filings/0001493152-26-008037.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-008037 |
| 2026-02-23 | 19:56 ET | [SCHEDULE 13D/A](/filings/0001493152-26-007792.md) | Ownership report, active investor, amended | 0001493152-26-007792 |
| 2026-02-03 | 16:05 ET | [8-K](/filings/0001493152-26-004905.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-004905 |
| 2026-02-02 | 18:35 ET | [SCHEDULE 13D/A](/filings/0001493152-26-004801.md) | Ownership report, active investor, amended | 0001493152-26-004801 |
| 2026-01-27 | 09:08 ET | [8-K](/filings/0001493152-26-003715.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003715 |
| 2026-01-08 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001493152-26-000967.md) | Ownership report, active investor, amended | 0001493152-26-000967 |
| 2025-12-29 | 16:05 ET | [8-K](/filings/0001493152-25-029364.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029364 |
| 2025-11-18 | 18:15 ET | [8-K](/filings/0001493152-25-023942.md) | 1.02 Termination of a material agreement | 0001493152-25-023942 |
| 2025-11-14 | 16:11 ET | [10-Q](/filings/0001493152-25-023474.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023474 |
| 2025-11-14 | 16:05 ET | [8-K](/filings/0001493152-25-023419.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-023419 |
| 2025-11-07 | 16:05 ET | [8-K](/filings/0001493152-25-021255.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-021255 |
| 2025-09-17 | 06:05 ET | [8-K](/filings/0001493152-25-013815.md) | 8.01 Other events | 0001493152-25-013815 |
| 2025-09-10 | 08:00 ET | [8-K](/filings/0001493152-25-012952.md) | 8.01 Other events | 0001493152-25-012952 |
| 2025-08-25 | 17:00 ET | [8-K](/filings/0001641172-25-025405.md) | 8.01 Other events | 0001641172-25-025405 |
| 2025-08-13 | 17:02 ET | [10-Q](/filings/0001641172-25-023572.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023572 |
| 2025-08-13 | 17:01 ET | [8-K](/filings/0001641172-25-023570.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023570 |
| 2025-07-30 | 09:00 ET | [8-K](/filings/0001641172-25-021501.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-021501 |
| 2025-07-16 | 17:45 ET | [8-K](/filings/0001641172-25-019760.md) | 5.07 Shareholder vote results | 0001641172-25-019760 |
| 2025-07-07 | 17:25 ET | [8-K](/filings/0001641172-25-018042.md) | 3.01 Delisting notice | 0001641172-25-018042 |
| 2025-06-05 | 16:31 ET | [8-K](/filings/0001641172-25-013823.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-013823 |
| 2025-06-02 | 16:05 ET | [DEF 14A](/filings/0001641172-25-013237.md) | Proxy statement, period 2025-06-02 | 0001641172-25-013237 |
| 2025-05-21 | 09:00 ET | [8-K](/filings/0001641172-25-011873.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001641172-25-011873 |
| 2025-05-16 | 17:20 ET | [8-K](/filings/0001641172-25-011286.md) | 3.01 Delisting notice | 0001641172-25-011286 |
| 2025-05-14 | 09:01 ET | [8-K](/filings/0001641172-25-010112.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010112 |
| 2025-05-14 | 09:00 ET | [10-Q](/filings/0001641172-25-010111.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010111 |
| 2025-04-15 | 08:30 ET | [8-K](/filings/0001654954-25-004265.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-004265 |
| 2025-04-07 | 21:37 ET | [SCHEDULE 13D/A](/filings/0001641172-25-003085.md) | Ownership report, active investor, amended | 0001641172-25-003085 |
| 2025-04-03 | 18:00 ET | [SCHEDULE 13D/A](/filings/0001641172-25-002621.md) | Ownership report, active investor, amended | 0001641172-25-002621 |
| 2025-03-28 | 17:01 ET | [8-K](/filings/0001654954-25-003552.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-25-003552 |
| 2025-03-27 | 08:00 ET | [8-K](/filings/0001654954-25-003372.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-003372 |
| 2025-03-25 | 17:29 ET | [8-K](/filings/0001654954-25-003305.md) | 3.01 Delisting notice | 0001654954-25-003305 |
| 2025-03-17 | 16:17 ET | [8-K](/filings/0001654954-25-002886.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-002886 |
| 2025-03-17 | 16:15 ET | [10-K](/filings/0001654954-25-002885.md) | Annual report, period 2024-12-31 | 0001654954-25-002885 |
| 2025-02-13 | 18:00 ET | [SCHEDULE 13D/A](/filings/0001493152-25-006502.md) | Ownership report, active investor, amended | 0001493152-25-006502 |
| 2025-01-23 | 21:54 ET | [SCHEDULE 13D/A](/filings/0001493152-25-003484.md) | Ownership report, active investor, amended | 0001493152-25-003484 |
| 2025-01-23 | 16:16 ET | [8-K](/filings/0001654954-25-000681.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-000681 |
| 2025-01-21 | 08:05 ET | [8-K](/filings/0001654954-25-000570.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-000570 |
| 2024-11-14 | 18:03 ET | [8-K](/filings/0001654954-24-014289.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-014289 |
| 2024-11-13 | 16:16 ET | [10-Q](/filings/0001654954-24-014274.md) | Quarterly report, period 2024-09-30 | 0001654954-24-014274 |

Page 1 of 3. [Older](/companies/drma/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:27 ET. No prices; not investment advice.